Back to News
Market Impact: 0.2
Thursday's ETF Movers: ARKG, TAN
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
The ARK Genomic Revolution ETF rose about 2.6% in Thursday trading, outperforming other ETFs. Key contributors included CareDx, up roughly 13.5%, and Twist Bioscience, up about 10.6%, signaling strong risk appetite for select genomic and biotech equities.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.32
Ticker Sentiment
CDNA0.62
TWST0.52
More News
- Eurobio Scientific: Results for the first semester of fiscal year 2026
- Eurobio Scientific: Résultat du 1er semestre 2026
- History shows financial calamities occur when rates rise rapidly like this: 'Something always breaks'
- Surging Treasury yields are posing a brand new problem for Kevin Warsh and the Fed
- Yields are soaring to levels not seen in decades. What could stop the rout in bonds?
- Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Search Earnings Call Transcripts With AI
- What a Concept From Nature Tells Us About How C-Suite Executives Actually Think About AI